Pioglitazone News and Research

RSS
Mylan confirms Actoplus Met XR patent challenge

Mylan confirms Actoplus Met XR patent challenge

Positive results from Aestus' ATx08-001 Phase II study on post-herpetic neuralgia

Positive results from Aestus' ATx08-001 Phase II study on post-herpetic neuralgia

Takeda submits alogliptin plus metformin NDA to FDA for treatment of type 2 diabetes

Takeda submits alogliptin plus metformin NDA to FDA for treatment of type 2 diabetes

FDA assigns new PDUFA date for Takeda's investigational type 2 diabetes therapy, alogliptin

FDA assigns new PDUFA date for Takeda's investigational type 2 diabetes therapy, alogliptin

Glitazone treatment does not cause side effects in patients with metastatic thyroid cancer

Glitazone treatment does not cause side effects in patients with metastatic thyroid cancer

Increasing levels of 'good' cholesterol reduces risk for heart attack and stroke among diabetics

Increasing levels of 'good' cholesterol reduces risk for heart attack and stroke among diabetics

Linagliptin demonstrates durable reductions in blood glucose for T2D adults

Linagliptin demonstrates durable reductions in blood glucose for T2D adults

Researchers create powerful anti-diabetic prototype drugs with lesser side effects

Researchers create powerful anti-diabetic prototype drugs with lesser side effects

Takeda resubmits alogliptin and fixed-dose combination therapy NDA to FDA

Takeda resubmits alogliptin and fixed-dose combination therapy NDA to FDA

ChemoCentryx CCX140 Phase II study on type 2 diabetes meets primary endpoint

ChemoCentryx CCX140 Phase II study on type 2 diabetes meets primary endpoint

Inhaled corticosteroids linked to increased risk of fractures in patients with COPD

Inhaled corticosteroids linked to increased risk of fractures in patients with COPD

Amylin to present data on investigational diabetes drug candidates at ADA annual meeting

Amylin to present data on investigational diabetes drug candidates at ADA annual meeting

Medical societies urge diabetes patients to remain on their prescribed medications

Medical societies urge diabetes patients to remain on their prescribed medications

AGA's cutting-edge research on GI disorders to be presented at DDW 2011

AGA's cutting-edge research on GI disorders to be presented at DDW 2011

Boehringer Ingelheim, Eli Lilly receive FDA approval for linagliptin to treat type 2 diabetes

Boehringer Ingelheim, Eli Lilly receive FDA approval for linagliptin to treat type 2 diabetes

Boehringer Ingelheim, Eli Lilly receive FDA approval for Tradjenta to treat type 2 diabetes

Boehringer Ingelheim, Eli Lilly receive FDA approval for Tradjenta to treat type 2 diabetes

Diabetes and prediabetes are on the rise: New medication in research trials

Diabetes and prediabetes are on the rise: New medication in research trials

TZDs might serve as new agents for addiction treatment

TZDs might serve as new agents for addiction treatment

Metabolic Solutions initiates MSDC-0602 Phase 2a trial in patients with type 2 diabetes

Metabolic Solutions initiates MSDC-0602 Phase 2a trial in patients with type 2 diabetes

Positive results from exenatide phase 2 study in patients with type 2 diabetes

Positive results from exenatide phase 2 study in patients with type 2 diabetes